SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Alvotech (ALVO) trades at a trailing P/E of 35.3, forward P/E of 110.7. Trailing earnings yield is 2.84%, forward earnings yield 0.90%. PEG 0.81 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (85/100, Pass) — PEG ≤ 1.0 — Peter Lynch undervalued (0.81); analyst target implies upside (+143.6%).
- PEG Ratio 0.81 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 2.84% — below bond yields — investors are paying a premium for expected growth rather than current earnings.
- Analyst consensus target $8.60 (+143.6% upside) — significant upside potential according to Wall Street analysts.
Overall SharesGrow Score: 59/100 with 3/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
85/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — ALVO
Valuation Multiples
P/E (TTM)35.3
Forward P/E110.7
PEG Ratio0.81
Forward PEG0.81
P/B Ratio-3.46
P/S Ratio1.87
EV/EBITDA30.4
Per Share Data
EPS (TTM)$0.10
Forward EPS (Est.)$0.03
Book Value / Share$-1.02
Revenue / Share$2.10
FCF / Share$-0.41
Yields & Fair Value
Earnings Yield2.84%
Forward Earnings Yield0.90%
Dividend Yield0.00%
SharesGrow IV$76.24 (+2059.8%)
Analyst Target$8.60 (+143.6%)
Historical Valuation
| Year |
P/E (TTM) |
PEG Ratio |
P/B Ratio |
P/S Ratio |
Dividend Yield |
| 2019 |
-13.0 |
0.00 |
0.00 |
85.42 |
- |
| 2020 |
-2.1 |
0.00 |
-0.40 |
5.25 |
- |
| 2021 |
-3.4 |
0.09 |
-2.58 |
9.51 |
- |
| 2022 |
-3.8 |
0.19 |
-3.50 |
23.81 |
- |
| 2023 |
-4.7 |
0.72 |
-2.80 |
28.53 |
- |
| 2024 |
-15.3 |
0.24 |
-8.59 |
7.24 |
- |
| 2025 |
51.3 |
-0.46 |
-5.03 |
2.44 |
- |
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2019 |
$-0.86 |
$31.92M |
$-209.88M |
-657.5% |
| 2020 |
$-5.44 |
$66.62M |
$-170.04M |
-255.3% |
| 2021 |
$-3.25 |
$36.77M |
$-101.5M |
-276% |
| 2022 |
$-2.60 |
$83.03M |
$-513.58M |
-618.6% |
| 2023 |
$-2.43 |
$91.43M |
$-551.73M |
-603.4% |
| 2024 |
$-0.87 |
$489.68M |
$-231.86M |
-47.3% |
| 2025 |
$0.10 |
$586.32M |
$27.92M |
4.8% |
Analyst Estimates
| Year |
EPS (Avg) |
EPS Range |
Revenue (Avg) |
Revenue Range |
Analysts |
| 2026 |
$0.03 |
$-0.01 – $0.10 |
$603.32M |
$585.83M – $620.79M |
3 |
| 2027 |
$0.21 |
$-0.01 – $0.40 |
$750.72M |
$639.13M – $846.37M |
3 |
| 2028 |
$0.45 |
$0.18 – $0.91 |
$940.32M |
$920.22M – $960.41M |
3 |
| 2029 |
$0.90 |
$0.77 – $1.08 |
$1.19B |
$1.05B – $1.37B |
1 |
| 2030 |
$1.01 |
$0.87 – $1.21 |
$1.27B |
$1.13B – $1.46B |
1 |
